iShares Biotechnology ETF (NASDAQ:IBB) Stake Boosted by Kovitz Investment Group Partners LLC

Kovitz Investment Group Partners LLC boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 38.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 4,192 shares of the financial services provider’s stock after purchasing an additional 1,154 shares during the quarter. Kovitz Investment Group Partners LLC’s holdings in iShares Biotechnology ETF were worth $610,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Quantinno Capital Management LP purchased a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $244,000. Pinnacle Family Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $3,347,000. Maven Securities LTD purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $2,237,000. Ingalls & Snyder LLC acquired a new stake in iShares Biotechnology ETF during the third quarter valued at $233,000. Finally, Cladis Investment Advisory LLC grew its stake in iShares Biotechnology ETF by 41.7% in the third quarter. Cladis Investment Advisory LLC now owns 4,300 shares of the financial services provider’s stock valued at $626,000 after purchasing an additional 1,265 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 1.7 %

IBB opened at $137.67 on Friday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business has a 50-day moving average of $141.99 and a 200-day moving average of $142.24.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.